Table 7.
Classification of interventions based on network meta-analysis on alleviating global symptoms at 2-week follow-up: domperidone as the comparator
| Classification of intervention | CHM formula | Risk difference (95% CI) | Surface under the cumulative ranking curve | Certainty of evidence+ |
|---|---|---|---|---|
| Small beneficial effect† | Cai Hu Shu Gan Powder | 0.16 (− 0.06, 0.50) | 0.79 | Low |
| Wei Kang Ping Decoction | 0.16 (− 0.07, 0.49) | 0.79 | Low | |
| Trivial to no beneficial effect‡ | Tiao Zhong Xiao Pi Decoction | 0.06 (− 0.11, 0.29) | 0.50 | Low |
| Wu Mo Decoction | 0.06 (− 0.12, 0.30) | 0.50 | Low | |
| Ban Xia Xie Xin Decoction | 0.02 (− 0.15, 0.26) | 0.36 | Low | |
| Qi Zhi Wei Tong Granules | 0.01 (− 0.14, 0.22) | 0.30 | Low |
CHM Chinese herbal medicine, CI Confidence interval
†Small beneficial effect: 0.20 > risk difference ≥ 0.08
‡Trivial to no beneficial effect: risk difference < 0.08
+Quality of evidence ratings for comparisons in network meta-analysis on alleviating global symptoms at 2-week follow-up (domperidone as the comparator). Details refer to Additional file 1: Appendix 5